Current page location
HOME > Research Fields > Rare Disease Research Center
Rare Disease Research Center

Development of precision and customized medicine original technology for rare neurological diseases based on big data
- Establishment of CNV map related to neurological diseases for Koreans
- Development of precise diagnostics for neurological diseases
- Identification of precision and customized treatment target for neurological diseases
researchers and research statement
Name |
Research Fields |
Nam-Soon Kim (Associate Director) |
- Genome and functional study of rare neuronal diseases
- Functional genomics of cancer
- Management of Korea Human Gene Bank (KHGB)
|
Jae-Ran Lee |
- Functional analysis of synaptic molecules related to rare neuronal diseases
- Discovery of biomarkers for early diagnosis of neuro developmental disorders
|
Kyung Sook Chung |
- Development of molecular diagnostics for rare neuronal diseases
- Cancer therapies development
- Development of biomimetic 3D liver and toxicity analysis platform
|
Eun-Wie Cho |
- Cancer molecular cell biology and biochemistry
- Development of molecular diagnostics for rare neuronal diseases
|
Dae-Soo Kim |
- Genome study of neurological disorder genes using NGS
- Construction of genome analysis infrastructure for neurological disorders
|
Da Yong Lee |
- Neuroscience
- Developmental neurobiology
|
Jeong Ju Lee |
- Large-scale collection and distribution of human cDNA clones
- Operation of Korea Human Gene Bank (KHGB)
|
- Securing high quality clinical sample, clinical information and genome information related to rare neurological diseases
- Establishment of Korean standard CNV map for rare neurological diseases and establishment of integrated DB
- Development of precise diagnostics original technology related to rare neurological diseases
- Exploration of precision, customized treatment target related to rare neurological diseases and identification of function and mechanism

- Discovery of new variation regarding the cause of brain development disorder and development of animal model
- Finding out that various de novo mutations in nerve cell specific KIF1A motor domain cause intellectual developmental disorder, spastic paralysis, axon disorder, cerebellar atrophy
- Production of in vivo animal model related to TSC genetic brain developmental diseases
- Completion of the system to identify brain developmental disease diagnostics marker using in vitro neural stem cell cultivation system
- Establishment of the disease specific large NGS genome data production and analysis pipeline
- Completion of the system development for handling, processing and analyzing large volume NGS genome data and multiple bio big data in different data structure
- Identification of various SNV/INDEL candidates related to diseases using clinical sample and NGS data in Public DB and establishment of technology for integrated analysis of genome information and information standardization
- Establishment of CNV map and DB related to diseases
- Identification of targets and research on mechanism to genome based treatment
- Presenting the role of TIPRL resistant to new TRAIL carcinostatis substance as a TRAIL sensitizer
- Securing the Site specific Histone methylation
- Patent registration related to new GPCR protein and other purposes (US, Europe, China)
- Identification of biomarker, development of cancer diagnostics and commercialization based on autoimmune antibodies in the blood
- Establishment of the infrastructure for whole human genome clone and expression clone necessary for the functional research on disease target